Naofumi Shimmyo

Association study of MIF promoter polymorphisms with suicide completers in the Japanese population

I. Sora, Tadasu Horai, S. Okazaki, 2017, Neuropsychiatric disease and treatment.

Searching for biomarkers in schizophrenia and psychosis: Case‐control study using capillary electrophoresis and liquid chromatography time‐of‐flight mass spectrometry and systematic review for biofluid metabolites

I. Sora, Tadasu Horai, S. Okazaki, 2021, Neuropsychopharmacology reports.

Polymorphisms in the hypoxia inducible factor binding site of the macrophage migration inhibitory factor gene promoter in schizophrenia

Tadasu Horai, S. Okazaki, Yuichiro Watanabe, 2022, PloS one.

Clozapine increases macrophage migration inhibitory factor (MIF) expression via increasing histone acetylation of MIF promoter in astrocytes.

Tadasu Horai, S. Okazaki, Ikuo Otsuka, 2021, Journal of psychiatric research.

Increased serum levels and promoter polymorphisms of macrophage migration inhibitory factor in schizophrenia

I. Sora, S. Okazaki, M. Kinoshita, 2018, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

A cross-sectional study exploring useful indicators for low bone mineral density in male alcoholic patients

I. Sora, Tadasu Horai, Ikuo Otsuka, 2018, Neuropsychiatric disease and treatment.